As the impacts of climate change are becoming increasingly severe worldwide, Keystone Symposia and the Global Consortium for Climate Health and Education have joined forces to raise awareness for how climate change impacts human health, and what we as scientists can do to apply our skills and knowledge toward increasing our understanding of health impacts and viable solutions to minimize harms. In a series of ePanels with climate medicine experts, we will explore how increasing frequency and severity of heat waves, wildfires, drought, flooding and other extreme weather events is fueling a global health crisis, particularly amongst vulnerable populations.
From heat-related illness, to respiratory, cardiovascular, waterborne gastrointestinal and vector-borne diseases, the global disease burden due to climate change is vast and ever-rising. With impending climate crisis, we are likely to reach a tipping point sooner rather than later as healthcare systems and providers are stretched to capacity. It is critical that the biomedical community engage now to understand these impacts, and design interventions to mitigate the damage to human health worldwide.
In this ePanel series we will examine:
mechanisms linking climate change to disease pathology
health impacts from physiological to epidemiological levels
tools to measure and analyze health impacts to inform decisions and action
current interventions, successes and failures
health disparities and disproportionate impacts on vulnerable populations
Ultimately, the goal of these discussions is to open up lines of communication between scientists, clinicians, public health experts and policy makers to collectively assess the threats posed by climate change, and devise strategies to curtail the looming climate health crisis.
Join us for our upcoming ePanel Series on Climate Health!
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.